Kolkailah AA, Wiviott SD, Raz I, Murphy SA, et al. Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58. Diabetes Care 2022 Jan 12. pii: 139334. doi: 10.2337/dc21-1668.
PMID: 35020832